📊 CC Key Takeaways
Is Chemours Co (CC) a Good Investment?
Chemours is in severe financial distress with persistent operating losses, negative free cash flow of -$93M, and a critically unsustainable debt-to-equity ratio of 19.07x that prevents interest coverage. The company cannot service its $4.1B debt burden from operations and faces acute solvency risk without significant operational turnaround.
Chemours' fundamentals are under significant pressure: revenue is essentially flat, but margins have deteriorated sharply into operating and net losses, while ROE and interest coverage indicate a severely strained capital structure. The company still generates positive operating cash flow and modest free cash flow, and liquidity is not immediately distressed, but weak profitability and very high leverage materially reduce financial flexibility. Until margins, earnings quality, and balance sheet strength improve, the fundamental profile remains unattractive.
Why Buy Chemours Co Stock? CC Key Strengths
- Maintains $563M cash reserves providing near-term liquidity buffer
- Gross margin of 15.4% provides runway for operational improvements
- Current ratio of 1.82x indicates adequate short-term working capital
- Positive operating cash flow and modest free cash flow despite net losses
- Adequate near-term liquidity with a 1.78x current ratio and $670M in cash
- Revenue has remained relatively stable year over year
CC Stock Risks: Chemours Co Investment Risks
- Negative free cash flow of -$93M annually means unsustainable cash burn at current pace
- Debt-to-equity of 19.07x with negative interest coverage (-0.3x) indicates inability to service debt from operations
- Operating losses destroying shareholder value (ROE -13.5%, ROA -0.4%)
- Flat revenue growth of +0.4% YoY provides no organic growth to support debt reduction
- Quick ratio of 0.87x below 1.0 signals potential liquidity stress beyond cash reserves
- Negative operating margin and net margin indicate poor earnings quality and weak cost absorption
- Extremely high leverage with debt/equity of 16.40x and only $250M of equity
- Negative interest coverage suggests earnings are insufficient to support debt burden
Key Metrics to Watch
- Operating cash flow trend (must turn positive for survival)
- Operating margin improvement trajectory
- Debt refinancing ability and interest expense coverage
- Revenue growth acceleration to generate cash
- Cash runway depletion rate at current burn pace
- Operating margin and gross margin recovery
- Free cash flow generation relative to debt and interest obligations
Chemours Co (CC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Chemours Co presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
CC Profit Margin, ROE & Profitability Analysis
CC vs Materials Sector: How Chemours Co Compares
How Chemours Co compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Chemours Co Stock Overvalued? CC Valuation Analysis 2026
Based on fundamental analysis, Chemours Co shows some fundamental concerns relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Chemours Co Balance Sheet: CC Debt, Cash & Liquidity
CC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Chemours Co's revenue has remained relatively flat over the 5-year period, with a 4% decline. The most recent EPS of $-1.70 indicates the company is currently unprofitable.
CC Revenue Growth, EPS Growth & YoY Performance
CC Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1.4B | -$5.0M | $-0.03 |
| Q3 2025 | $1.5B | -$32.0M | $-0.22 |
| Q2 2025 | $1.6B | $60.0M | $0.39 |
| Q1 2025 | $1.4B | -$4.0M | $-0.03 |
| Q3 2024 | $1.5B | $12.0M | $0.08 |
| Q2 2024 | $1.5B | $70.0M | $0.46 |
| Q1 2024 | $1.4B | $52.0M | $0.34 |
| Q3 2023 | $1.5B | $20.0M | $0.13 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Chemours Co Dividends, Buybacks & Capital Allocation
CC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Chemours Co (CIK: 0001627223)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CC
What is the AI rating for CC?
Chemours Co (CC) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 90% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CC's key strengths?
Claude: Maintains $563M cash reserves providing near-term liquidity buffer. Gross margin of 15.4% provides runway for operational improvements. ChatGPT: Positive operating cash flow and modest free cash flow despite net losses. Adequate near-term liquidity with a 1.78x current ratio and $670M in cash.
What are the risks of investing in CC?
Claude: Negative free cash flow of -$93M annually means unsustainable cash burn at current pace. Debt-to-equity of 19.07x with negative interest coverage (-0.3x) indicates inability to service debt from operations. ChatGPT: Negative operating margin and net margin indicate poor earnings quality and weak cost absorption. Extremely high leverage with debt/equity of 16.40x and only $250M of equity.
What is CC's revenue and growth?
Chemours Co reported revenue of $1.4B.
Does CC pay dividends?
Chemours Co pays dividends, with $13.0M distributed to shareholders in the trailing twelve months.
Where can I find CC SEC filings?
Official SEC filings for Chemours Co (CIK: 0001627223) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CC's EPS?
Chemours Co has a diluted EPS of $-0.19.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CC a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Chemours Co has a SELL rating with 90% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CC stock overvalued or undervalued?
Valuation metrics for CC: ROE of -13.5% (sector avg: 14%), net margin of -2.1% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy CC stock in 2026?
Our dual AI analysis gives Chemours Co a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CC's free cash flow?
Chemours Co's operating cash flow is $-44.0M, with capital expenditures of $49.0M. FCF margin is -6.7%.
How does CC compare to other Materials stocks?
Vs Materials sector averages: Net margin -2.1% (avg: 10%), ROE -13.5% (avg: 14%), current ratio 1.82 (avg: 1.6).
Is Chemours Co carrying too much debt?
CC has a debt-to-equity ratio of 19.07x, which is above the Materials sector average of 0.6x. However, the current ratio of 1.82 suggests adequate short-term liquidity.